BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9254766)

  • 1. Ischaemic preconditioning does not protect hypertrophied myocardium against ischaemia.
    Moolman JA; Genade S; Tromp E; Opie LH; Lochner A
    S Afr Med J; 1997 Jun; 87 Suppl 3():C151-6. PubMed ID: 9254766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-arrhythmic protection by ischaemic preconditioning in isolated rat hearts is not due to depletion of endogenous catecholamines.
    Lawson CS; Hearse DJ
    Cardiovasc Res; 1996 Apr; 31(4):655-62. PubMed ID: 8689659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischaemic preconditioning protects against myocardial dysfunction caused by ischaemia in isolated hypertrophied rat hearts.
    Pantos CI; Davos CH; Carageorgiou HC; Varonos DV; Cokkinos DV
    Basic Res Cardiol; 1996; 91(6):444-9. PubMed ID: 8996629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy.
    Ebrahim Z; Yellon DM; Baxter GF
    Pharmacol Res; 2007 Jan; 55(1):42-8. PubMed ID: 17079163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery.
    Lochner A; Genade S; Moolman JA
    Basic Res Cardiol; 2003 Sep; 98(5):337-46. PubMed ID: 12955407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heart.
    Weselcouch EO; Baird AJ; Sleph PG; Dzwonczyk S; Murray HN; Grover GJ
    Cardiovasc Res; 1995 Jan; 29(1):126-32. PubMed ID: 7895230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischaemic preconditioning protects hypertrophied myocardium.
    Speechly-Dick ME; Baxter GF; Yellon DM
    Cardiovasc Res; 1994 Jul; 28(7):1025-9. PubMed ID: 7954588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
    Fan WJ; van Vuuren D; Genade S; Lochner A
    Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvascular preconditioning is not detectable by corrosion casting in the isolated perfused rat heart after 30 minutes of ischaemia.
    Arangannal A; McGarrity A; Wheatley DJ; Belcher PR
    Scand Cardiovasc J; 2008 Feb; 42(1):90-5. PubMed ID: 18273729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein in acute and delayed preconditioning of the rat heart.
    Valtchanova-Matchouganska A; Gondwe M; Nadar A
    Cardiovasc J S Afr; 2005; 16(2):118-23. PubMed ID: 15915280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to ischaemia and ischaemic preconditioning in neonatal rat heart.
    Ostadalova I; Ostadal B; Kolár F; Parratt JR; Wilson S
    J Mol Cell Cardiol; 1998 Apr; 30(4):857-65. PubMed ID: 9602435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension.
    Ebrahim Z; Yellon DM; Baxter GF
    Exp Gerontol; 2007 Aug; 42(8):807-14. PubMed ID: 17532161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of preconditioning on post-ischaemic myocardial performance in the absence of substantial infarction and in extensively infarcted rat hearts.
    Efstathiou A; Seraskeris S; Papakonstantinou C; Aidonopoulos A; Lazou A
    Eur J Cardiothorac Surg; 2001 Apr; 19(4):493-9. PubMed ID: 11306319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic preconditioning maintains cardioprotection in aging normotensive and spontaneously hypertensive rats.
    Dai W; Simkhovich BZ; Kloner RA
    Exp Gerontol; 2009 May; 44(5):344-9. PubMed ID: 19248825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischaemic preconditioning reduces infarct size following global ischaemia in the murine myocardium.
    Sumeray MS; Yellon DM
    Basic Res Cardiol; 1998 Oct; 93(5):384-90. PubMed ID: 9833150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischaemic episodes of less than 5 minutes produce preconditioning but not stunning in the isolated rat heart.
    Schjøtt J; Jynge P; Holten T; Brurok H
    Acta Physiol Scand; 1994 Mar; 150(3):281-91. PubMed ID: 8010135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor stimulation acts as mediator of protection in ischaemic preconditioning.
    Genade S; Moolman JA; Lochner A
    Cardiovasc J S Afr; 2001; 12(1):8-16. PubMed ID: 11447487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.